Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Burkhard Tümmler

Showing results (1-10 of 219) with videos related to

Pageof 22
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 20, 2025
The multiple tales on sweat chloride in cystic fibrosisBurkhard Tümmler
The Journal of Clinical Investigation|October 16, 2023
Puzzle resolved: CFTR mediates chloride homeostasis by segregating absorption and secretion to different cell typesBurkhard Tümmler
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 4, 2019
Mild cystic fibrosis in carriers of two nonsense mutations - a case of genetic compensation response?Burkhard Tümmler
Advances in Experimental Medicine and Biology|October 18, 2022
What Makes Pseudomonas aeruginosa a Pathogen?Burkhard Tümmler
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
In-vivo and ex-vivo functional assessmentBurkhard Tümmler
Biochimica Et Biophysica Acta|May 23, 2006
Rescue of F508del CFTR: Commentary on "F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive"Burkhard Tümmler
Frontiers in Pharmacology|April 7, 2023
Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor-IvacaftorBurkhard Tümmler
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2025
Adhesion of Pseudomonas aeruginosa to Human Outer Layer Airway MucinsBurkhard Tümmler
The Lancet. Respiratory Medicine|October 2, 2019
Progress in understanding the molecular pathology and microbiology of cystic fibrosisBurkhard Tümmler
The Lancet. Respiratory Medicine|January 28, 2014
Mutation-specific therapy in cystic fibrosis: the earlier, the betterBurkhard Tümmler
Pageof 22

Showing results (1-10 of 219) with videos related to

Sort By:
Pageof 22
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 20, 2025
The multiple tales on sweat chloride in cystic fibrosisBurkhard Tümmler
The Journal of Clinical Investigation|October 16, 2023
Puzzle resolved: CFTR mediates chloride homeostasis by segregating absorption and secretion to different cell typesBurkhard Tümmler
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 4, 2019
Mild cystic fibrosis in carriers of two nonsense mutations - a case of genetic compensation response?Burkhard Tümmler
Advances in Experimental Medicine and Biology|October 18, 2022
What Makes Pseudomonas aeruginosa a Pathogen?Burkhard Tümmler
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 7, 2004
In-vivo and ex-vivo functional assessmentBurkhard Tümmler
Biochimica Et Biophysica Acta|May 23, 2006
Rescue of F508del CFTR: Commentary on "F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive"Burkhard Tümmler
Frontiers in Pharmacology|April 7, 2023
Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor-IvacaftorBurkhard Tümmler
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2025
Adhesion of Pseudomonas aeruginosa to Human Outer Layer Airway MucinsBurkhard Tümmler
The Lancet. Respiratory Medicine|October 2, 2019
Progress in understanding the molecular pathology and microbiology of cystic fibrosisBurkhard Tümmler
The Lancet. Respiratory Medicine|January 28, 2014
Mutation-specific therapy in cystic fibrosis: the earlier, the betterBurkhard Tümmler
Pageof 22